Research
Molecular
Advances in understanding molecular causes of rare genetic obesities have led to therapies targeting appetite regulation.
Practitioners should consider new therapies targeting appetite regulation for patients with rare genetic obesities.
StrongSupportsmedium confidence
Advances in our understanding of the molecular causes of rare genetic obesities, particularly those affecting hypothalamic function, have paved the way for current and emerging, therapies specifically targeting appetite regulation.
Why this rating
The abstract discusses current and emerging therapies based on advances in molecular understanding.
Source
From genes to care: the expanding therapeutic horizon in rare genetic obesities
Sarah Chalopin et al. · Obesity and Endocrinology · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →